Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$51.4B |
| 2 |
Broadcom
AVGO
|
+$8.12B |
| 3 |
NVIDIA
NVDA
|
+$6.62B |
| 4 |
UnitedHealth
UNH
|
+$5.92B |
| 5 |
Apple
AAPL
|
+$5.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$14.9B |
| 2 |
Meta Platforms (Facebook)
META
|
+$12.7B |
| 3 |
SNDK
Sandisk
SNDK
|
+$7.89B |
| 4 |
Netflix
NFLX
|
+$6.05B |
| 5 |
Coherent
COHR
|
+$4.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.62% |
| 2 | Industrials | 10.81% |
| 3 | Communication Services | 9.9% |
| 4 | Healthcare | 9.29% |
| 5 | Financials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
First Trust Health Care AlphaDEX Fund
FXH
$1.14B
| $379K | ﹤0.01% |
3,097
+187
| +6% | +$21.4K |
|
3202
iShares Latin America 40 ETF
ILF
$3.92B
| $378K | ﹤0.01% |
11,201
+4,659
| +71% | +$165K |
|
3203
Keros Therapeutics
KROS
$221M
| $378K | ﹤0.01% |
35,328
+2,654
| +8% | +$29.6K |
|
3204
SELLAS Life Sciences
SLS
$2.28B
| $377K | ﹤0.01% |
25,533
+9,972
| +64% | +$68.8K |
|
3205
Alico
ALCO
$295M
| $375K | ﹤0.01% |
9,065
-131
| -1% | -$5.43K |
|
3206
TFS Financial
TFSL
$4.79B
| $375K | ﹤0.01% |
21,135
+3,092
| +17% | +$48.2K |
|
3207
EyePoint Inc
EYPT
$316M
| $374K | ﹤0.01% |
26,155
-103,283
| -80% | -$1.38M |
|
3208
JPMorgan US Momentum Factor ETF
JMOM
$2.68B
| $373K | ﹤0.01% |
4,363
-415
| -9% | -$32.6K |
|
3209
Triumph Financial Inc
TFIN
$1.55B
| $373K | ﹤0.01% |
4,886
+1,314
| +37% | +$89.4K |
|
3210
Embecta
EMBC
$288M
| $371K | ﹤0.01% |
113,955
+110,853
| +3,574% | +$605K |
|
3211
Peabody Energy
BTU
$3.25B
| $371K | ﹤0.01% |
16,038
-36,914
| -70% | -$981K |
|
3212
VictoryShares US 500 Volatility Wtd ETF
CFA
$520M
| $371K | ﹤0.01% |
3,751
+613
| +20% | +$58.7K |
|
3213
Boise Cascade
BCC
$2.65B
| $370K | ﹤0.01% |
4,762
-489,166
| -99% | -$36.3M |
|
3214
JPMorgan Equity Focus ETF
JPEF
$1.99B
| $370K | ﹤0.01% |
4,601
+4,165
| +955% | +$327K |
|
3215
United Parks & Resorts
PRKS
$1.63B
| $368K | ﹤0.01% |
7,715
+592
| +8% | +$23K |
|
3216
Nkarta
NKTX
$206M
| $368K | ﹤0.01% |
129,942
+843
| +0.7% | +$2.37K |
|
3217
Freedom 100 Emerging Markets ETF
FRDM
$3.44B
| $367K | ﹤0.01% |
5,037
+1,350
| +37% | +$90.2K |
|
3218
JPMorgan BetaBuilders International Equity ETF
BBIN
$6.65B
| $366K | ﹤0.01% |
4,693
+1,534
| +49% | +$119K |
|
3219
VanEck Pharmaceutical ETF
PPH
$1B
| $365K | ﹤0.01% |
3,341
+857
| +35% | +$88.7K |
|
3220
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.17B
| $365K | ﹤0.01% |
8,031
+4,106
| +105% | +$173K |
|
3221
Franklin US Large Cap Multifactor Index ETF
FLQL
$2.1B
| $361K | ﹤0.01% |
4,605
-13
| -0.3% | -$979 |
|
|
EROC
3222
ERock Inc
EROC
$532M
| $360K | ﹤0.01% |
+24,849
| New | +$396K |
|
3223
Editas Medicine
EDIT
$404M
| $360K | ﹤0.01% |
111,198
+4,418
| +4% | +$12.9K |
|
|
TIC
3224
TIC Solutions Inc
TIC
$2.1B
| $358K | ﹤0.01% |
44,311
-855
| -2% | -$7.21K |
|
3225
Invesco Bloomberg Pricing Power ETF
POWA
$167M
| $357K | ﹤0.01% |
4,023
-1,827
| -31% | -$160K |
|
Similar funds
Fidelity Investments's Q2 2026 Portfolio in Review
As of Q2 2026, Fidelity Investments held 5,773 positions worth $2.3T, up 21% from $1.9T the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Fidelity Investments's Q2 2026 filing shows 351 new, 2,921 increased, 1,859 reduced and 211 closed positions. Its largest new stake was SpaceX: 302,555,831 shares worth $51.7B. The largest sale was Marvell Technology, an estimated $14.9B.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 32% a quarter earlier, followed by Industrials and Communication Services.
- Fidelity Investments's largest Q2 2026 buy was SpaceX: 302,555,831 shares worth $51.7B.
- Fidelity Investments added most to Broadcom in Q2 2026, an estimated $8.12B increase.
- Fidelity Investments's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $14.9B.
- Fidelity Investments fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $272M.
- Fidelity Investments's ten largest holdings make up 34% of its $2.3T portfolio in Q2 2026.
- Fidelity Investments opened 351 new positions and closed 211 in Q2 2026.
- Fidelity Investments's portfolio value rose 21% quarter-over-quarter to $2.3T.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.